Secoya Technologies is a spin-off of ULB. It has a portfolio of 4 technologies covering the key steps of the drug production process: continuous reactions, crystallisation, pervaporation and droplet generation.
The unique value proposition of Secoya is to:
(i) bring down these unit operations at the sub-millimetric scale to take benefit of a rigorous control of the operating conditions;
(ii) rely on continuous processing and smart scale-up to ensure production rates compatible with industrial needs; and
(iii) offer 4 complementary technologies.
Secoya will develop more synergies between the different steps.